SUBSCRIBE
SUBSCRIBE

Lonza

NEWS
Deals
Lonza to Host New Webinar – “Paper to EBR in 9 Months: How a Strong Collaboration Leads to Project Success”
Free Lonza webinar to discuss the benefits of a collaborative approach to implementing an Electronic Batch Record Platform
October 29, 2019
 · 
3 min read
Lonza’s Ibex™ Solutions to Support Genmab’s Growing Clinical Portfolio
Lonza’s Ibex™ Design planned to take Genmab’s pre-clinical candidates from gene to potential IND within 12 months
October 15, 2019
 · 
3 min read
Business
Prevail and Lonza Deepen Partnership with New Collaboration
The two companies will partner on the process development, analytical development and large-scale manufacturing for late-stage clinical and commercial supply.
October 8, 2019
 · 
2 min read
 · 
Alex Keown
Lonza’s MODA-ES™ Platform helps Nephron Pharmaceuticals move from paper to an EBR in nine months – Case study to be presented at 2019 ISPE Annual Meeting
Lonza has partnered with Nephron Pharmaceuticals Corporation to implement Lonza’s next-generation MODA-ES™ EBR Platform to streamline manufacturing compliance reporting
October 3, 2019
 · 
7 min read
Business
Lonza on Track to Deliver Full-Year 2019 Results, Driven by Pharma Biotech Business
Double-digit sales growth delivered by Pharma Biotech & Nutrition (LPBN) segment
July 24, 2019
 · 
16 min read
Policy
Lonza Expands Bioconjugation Facility and Announces Approval of Third Commercial ADC
Expansion to bioconjugation facility in Visp, Switzerland to meet increasing clinical, launch and commercial market demand
July 24, 2019
 · 
4 min read
Job Trends
Lonza Snaps up Drug Production Facility From Novartis
Financial details of the deal were not disclosed, but Lonza said it plans to retain the Novartis employees currently working at the facility.
July 1, 2019
 · 
2 min read
 · 
Alex Keown
Deals
Lonza Publishes Restated Financials for 2018
Lonza reports restated 2018 financials for sales, CORE EBITDA and CORE EBIT
June 20, 2019
 · 
3 min read
Carve-out of Lonza Specialty Ingredients will help segment to become a global leader in microbial control
Lonza Group announced its intention to proceed with a carve-out of its Specialty Ingredients segment.
June 3, 2019
 · 
3 min read
Load More
AWARDS
  • 2024 Best Places to Work
  • 2023 Best Places to Work
JOBS
IN THE PRESS
Business
Moderna and Lonza Announce Worldwide Strategic Collaboration to Manufacture Moderna’s Vaccine (mRNA-1273) Against Novel Coronavirus
May 1, 2020
 · 
11 min read
XORTX Appoints Lonza for GMP Manufacturing and Formulation of XRx-101 (Oxypurinol) for Coronavirus / COVID-19 Clinical Trials
April 30, 2020
 · 
9 min read
Lonza Launches New TheraPEAK™ SfAAV™ Medium to Boost and Optimize the Production of AAV in Sf9 Insect Cells
March 26, 2020
 · 
5 min read
Business
Triumvira Immunologics and Lonza Announce Collaboration to Develop Innovative Point-of-Care Manufacturing for TAC T-Cell Therapeutic Targeting Solid Tumors
March 24, 2020
 · 
5 min read
Business
Lonza Partners with Cryoport and Strengthens its ‘Vein-to-vein’ Delivery Network in Cell & Gene Therapy
November 5, 2019
 · 
7 min read
Business
Mesoblast and Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Cell Therapy
October 16, 2019
 · 
6 min read
Business
Omeros and Lonza Enter Long-Term Manufacturing Agreement for Commercial Supply of Narsoplimab
July 31, 2019
 · 
6 min read
Policy
ERS Genomics and Lonza Enter Into CRISPR/Cas9 Technology Licensing Deal
December 13, 2018
 · 
1 min read
Lonza Expands Ibex™ Solutions to Offer Complete Product Lifecycle Management in One Location
September 20, 2018
 · 
6 min read
Lonza Launches New Bioscience Website
July 2, 2018
 · 
3 min read
Load More